EFM
IONS icon

E Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

E Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Sell
5,569
-41,119
-88% -$3.09M 0.01% 308
2026
Q1 		$3.51M Buy
+46,688
New +$3.68M 0.1% 104
2025
Q2 		$638K Sell
16,160
-311
-2% -$10.2K 0.03% 202
2025
Q1 		$497K Sell
16,471
-397
-2% -$13K 0.02% 226
2024
Q4 		$590K Buy
16,868
+4,116
+32% +$154K 0.03% 204
2024
Q3 		$511K Buy
12,752
+2,497
+24% +$116K 0.03% 194
2024
Q2 		$489K Buy
10,255
+430
+4% +$17.6K 0.03% 179
2024
Q1 		$426K Sell
9,825
-40
-0.4% -$1.91K 0.03% 192
2023
Q4 		$499K Sell
9,865
-1,231
-11% -$59K 0.03% 169
2023
Q3 		$503K Buy
11,096
+108
+1% +$4.46K 0.04% 121
2023
Q2 		$451K Sell
10,988
-384
-3% -$14.8K 0.04% 129
2023
Q1 		$406K Buy
11,372
+100
+0.9% +$3.75K 0.03% 162
2022
Q4 		$426K Buy
11,272
+1,102
+11% +$46.4K 0.04% 168
2022
Q3 		$450K Sell
10,170
-2,427
-19% -$102K 0.04% 143
2022
Q2 		$466K Buy
12,597
+4,263
+51% +$161K 0.04% 157
2022
Q1 		$309K Buy
+8,334
New +$273K 0.01% 188

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

E Fund Management's IONS Position: Q2 2026 in Review

E Fund Management reduced its Ionis Pharmaceuticals (IONS) stake by 88% in Q2 2026, selling an estimated $3.09M and leaving 5,569 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #308.

E Fund Management first reported a position in IONS in Q1 2022 and has held it in 16 quarters since. The position peaked at $3.51M in Q1 2026. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • E Fund Management held 5,569 shares of Ionis Pharmaceuticals worth $442K as of Q2 2026.
  • E Fund Management sold 41,119 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.09M.
  • Ionis Pharmaceuticals made up 0.01% of E Fund Management's portfolio in Q2 2026, its #308 holding.
  • E Fund Management first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • E Fund Management's Ionis Pharmaceuticals position peaked at $3.51M in Q1 2026.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.